What is the dividend declared by SMS Pharmaceuticals? – SMS Pharmaceuticals Ltd, is a global player in API manufacturing having a strong research and manufacturing team supported by state-of-the-art facilities. The company’s Board of Directors approved a final dividend of ₹0.40 per share. This announcement followed a remarkable financial year where the company saw significant growth in sales and net profit.
SMS Pharmaceuticals Ltd declares a dividend of ₹0.40. The SMS Pharmaceuticals Dividend 2024 record date is 23rd Sep 2024 and the ex-dividend date is 23rd Sep 2024. SMS Pharmaceuticals Ltd has announced a generous dividend of ₹0.40 per equity share in a positive development for shareholders. This translates to a 40% payout of the face value (Rs 1), demonstrating the company’s commitment to rewarding its investors while maintaining balance for future growth. This news has been met with enthusiasm, and it will be interesting to see how it impacts the company’s stock price in the upcoming trading sessions. The SMS Pharmaceuticals Dividend payment date will be paid within stipulated timelines as prescribed under law.
What is a Dividend?
Before we dive into the specifics, it’s important to understand what a dividend is. A dividend is a portion of a company’s earnings distributed to its shareholders. It is a reward for their investment in the company. Companies usually pay dividends quarterly or annually. They can be in the form of cash, additional shares, or other property.
About SMS Pharmaceuticals Ltd
- SMS Pharmaceuticals Limited is a Small-cap Stock.
- SMS was given the export house status in the year 1997-98.
- The market capitalization of SMS Pharmaceuticals Ltd is ₹2,477 Crores. The company’s current chairman is P Ramesh Babu.
- Having four multi-product facilities in operation and two research centers, SMS has truly graduated into the big league with more than 1000+ employees working for it.
SMS Pharmaceuticals Share Price
- SMS Pharmaceuticals’ total revenue in Sep 2023 was ₹167.45 Crore, Dec 2023 was ₹162.97 Crore, in Mar 2024 was ₹247.44 Crore, and in Jun 2024 was ₹165.82 Crore.
- SMS Pharmaceuticals’ net income in Sep 2023 was ₹11.73 Crore, Dec 2023 was ₹11.48 Crore, in Mar 2024 was ₹17.27 Crore, and in Jun 2024 was ₹16.47 Crore.
- The company’s EBITDA in Sep 2023 was ₹28.63 Crore, Dec 2023 was ₹30.49 Crore, in Mar 2024 was ₹35.26 Crore, and in Jun 2024 was ₹34.88 Crore
- The company’s cash flow in 2021 was ₹7.66 Crore, in 2022 -₹9.48 Crore, and in 2023 -₹14.01 Crore.
SMS Pharmaceuticals Share Holding Pattern
| Investors | Holdings % |
| Promoter | 64.67% |
| Foreign Institutions | 0.17% |
| Mutual Funds | 2.13% |
| Retail Investors | 33.03% |
| Others | 0.00% |
Read More – Advantages of Stock Dividend
What is the dividend declared by SMS Pharmaceuticals? – SMS Pharmaceuticals Dividend History
Considering the current share price of SMS Pharmaceuticals, the dividend yield will provide an attractive return to shareholders. The company’s decision to increase the dividend payout aligns with its strategy to maintain a balanced approach towards growth and shareholder returns. This high dividend is a positive signal of the company’s profitability and efficient management for investors.
| Amount | Ex-Date |
| ₹0.30 | Sep 22, 2023 |
| ₹0.30 | Sep 22, 2022 |
| ₹0.30 | Sep 22, 2021 |
| ₹0.25 | Mar 26, 2020 |
| ₹0.25 | Sep 19, 2019 |
SMS Pharmaceuticals Share Price Target
SMS Pharmaceuticals Share Price Target 2024
India’s share market is at its peak, and most Indian stocks like SMS Pharmaceuticals Ltd experienced a bull run in 2023. In 2024, the bullish sentiment of the market will likely stay. As per data, the minimum share price target in 2024 for SMSPHARMA is expected to be ₹295.00 and the maximum price target in 2024 will be ₹324.00. With market conditions, the price target of SMS Pharmaceuticals Ltd may vary.
SMS Pharmaceuticals Share Price Target 2025
India’s share market is at its peak, and most Indian stocks like SMS Pharmaceuticals Ltd experienced a bull run in 2023. In 2025, the bullish sentiment of the market will likely stay. As per data, the minimum share price target in 2025 for SMSPHARMA is expected to be ₹324.00 and the maximum price target for 2025 will be ₹356.00. With market conditions, the price target of SMS Pharmaceuticals Ltd may vary.
SMS Pharmaceuticals Share Price Target 2030
India’s share market is at its peak, and most Indian stocks like SMS Pharmaceuticals Ltd experienced a bull run in 2023. In 2030, the market’s bullish sentiment will likely stay as India is a growing economy, and as per the government, India will become a $5 trillion economy by 2030. As per data, the minimum share price target in 2030 for SMSPHARMA is expected to be ₹600.00 and the maximum price target for 2030 will be ₹660.00. With market conditions, the price target of SMS Pharmaceuticals Ltd may vary.
Conclusion
The dividend announcement by SMS Pharmaceuticals is a testament to the company’s stellar performance in the financial year 2023-24. Shareholders can look forward to a substantial return on their investments, reflecting the company’s strong financial health and strategic growth initiatives. As SMS Pharmaceuticals continues to innovate and expand, it remains well-positioned to maintain its leadership in the automotive market, delivering value to its shareholders and customers alike.
This detailed analysis of SMS Pharmaceuticals’ financial performance and dividend declaration provides a comprehensive understanding of the company’s achievements and prospects. The dividend announcement marks a significant milestone in the company’s history, underscoring its commitment to growth and shareholder value.
Read More – High Dividend Small Cap Stocks